Global Strategic Product
Acquisitions and Co-Developments
With a focus on China's high-incidence cancers and the needs of Chinese patients, in-license attractive assets globally or custom design and develop through preclinical CROs
World-ClassLeverage the clinical team's industry-leading capabilities to accelerate clinical development & drug registration, while adhering to international standards and quality
Commercialize Products in China and Globally
Build internal commercial infrastructure in China
Co-develop and co-market outside China
To ensure quality, CStone keeps the most critical clinical development functions in-house; while collaborating with the best CROs to lower operating costs and conduct multiple clinical trials simultaneously
Leverage an innovative model to shorten the timeline for clinical development
Your privacy is important for us. We use cookies to enhance your experience when visiting our websites: performance cookies show us how you use this website, functional cookies remember your preferences and targeting cookies help us to share content relevant to you. Select “Accept all” for giving your consent to all cookies or select “Reject all” for using only strictly necessary cookies.
